These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [What may be expected from the therapy of otosclerosis using sodium fluoride?]. Chládek V; Slaninová B Cesk Otolaryngol; 1977 Oct; 26(5):267-71. PubMed ID: 603948 [No Abstract] [Full Text] [Related]
3. [Pathophysiology and treatment of otosclerosis. Use of sodium fluoride therapy]. Ivanović A; Mitrović M Vojnosanit Pregl; 1982; 39(2):95-9. PubMed ID: 7113022 [No Abstract] [Full Text] [Related]
9. Sodium fluoride for inactivation of the otosclerotic lesion. Present status. Shambaugh GE Arch Otolaryngol; 1969 Feb; 89(2):381-2. PubMed ID: 5763935 [No Abstract] [Full Text] [Related]
10. The sodium fluoride 'catch-22'. Shambaugh GE Arch Otolaryngol; 1982 Jan; 108(1):62. PubMed ID: 7053755 [No Abstract] [Full Text] [Related]
11. Sodium fluoride and the otosclerotic lesion. House HP; Linthicum FH Arch Otolaryngol; 1974 Dec; 100(6):427-30. PubMed ID: 4447482 [No Abstract] [Full Text] [Related]
12. The effect of sodium fluoride on otosclerotic activity as determined by strontium. Linthicum FH; House HP; Althaus SR Ann Otol Rhinol Laryngol; 1973; 82(4):609-15. PubMed ID: 4721187 [No Abstract] [Full Text] [Related]
14. Sodium fluoride in therapy of otosclerosis--does it cause atherosclerosis? Baron SH Laryngoscope; 1967 Aug; 77(8):1227-33. PubMed ID: 6072049 [No Abstract] [Full Text] [Related]
15. Editorial: therapeutic use of fluorides. Best EJ Dent Dig; 1966 Aug; 72(8):367. PubMed ID: 5221320 [No Abstract] [Full Text] [Related]
16. Modification with NaF in disequilibrium of otospongiotic origin. Bretlau P; Causse JB; Causse J Adv Otorhinolaryngol; 1982; 28():73-9. PubMed ID: 7113821 [No Abstract] [Full Text] [Related]
17. Ten years experience with fluoride in otosclerotic (otospongiotic) patients. Shambaugh GE; Causse J Ann Otol Rhinol Laryngol; 1974; 83(5):635-42. PubMed ID: 4416065 [No Abstract] [Full Text] [Related]
18. The possible value of sodium fluoride for inactivation of the otosclerotic bone lesion. Experimental and clinical studies. Shambaugh GE; Petrovic A Acta Otolaryngol; 1967 Apr; 63(4):331-9. PubMed ID: 6033657 [No Abstract] [Full Text] [Related]
19. Fluorides for otospongiosis and other osteoporotic states. Shambaugh GE Ann Otolaryngol Chir Cervicofac; 1973 Mar; 90(3):129-38. PubMed ID: 4717369 [No Abstract] [Full Text] [Related]
20. Sensorineural deafness due to cochlear otospongiosis: pathogenesis, clinical diagnosis, and therapy. Shambaugh GE Otolaryngol Clin North Am; 1978 Feb; 11(1):135-54. PubMed ID: 662341 [No Abstract] [Full Text] [Related] [Next] [New Search]